Novel approaches to develop biomarkers predicting treatment responses to TNF-blockers
Conclusions will be drawn about the possible development of predictive biomarkers for response to treatment.Expert opinion: No validated biomarker is currently available to predict treatment response in CID. New insight could be generated through the development of new bioinformatic modelling approaches to combine multidimensional biomarkers that explain the different genetic, immunological and environmental determinants of therapeutic responses.PMID:33622154 | DOI:10.1080/1744666X.2021.1894926
Source: Expert Review of Clinical Immunology - Category: Allergy & Immunology Authors: Ikram Mezghiche Hanane Yahia-Cherbal Lars Rogge Elisabetta Bianchi Source Type: research
More News: Allergy & Immunology | Arthritis | Chronic Pain | Environmental Health | Genetics | Inflammatory Bowel Disease | Pain | Rheumatoid Arthritis | Rheumatology | Study